{"id":40445,"date":"2025-04-21T16:28:39","date_gmt":"2025-04-21T08:28:39","guid":{"rendered":"https:\/\/www.cyberneus.com\/?p=40445"},"modified":"2025-04-21T16:28:39","modified_gmt":"2025-04-21T08:28:39","slug":"daan-biotherapeutics-and-gc-cell-sign-exclusive-technology-transfer-agreement-for-tumor-antigen-specific-antibody-sequence-to-advance-car-t-and-car-nk-cell-therapies-the-manila-times","status":"publish","type":"post","link":"https:\/\/www.cyberneus.com\/?p=40445","title":{"rendered":"DAAN Biotherapeutics and GC Cell Sign Exclusive Technology Transfer Agreement for Tumor Antigen-Specific Antibody Sequence to Advance CAR-T and CAR-NK Cell Therapies &#8211; The Manila Times"},"content":{"rendered":"<p><a href=\"https:\/\/news.google.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?oc=5\" target=\"_blank\">DAAN Biotherapeutics and GC Cell Sign Exclusive Technology Transfer Agreement for Tumor Antigen-Specific Antibody Sequence to Advance CAR-T and CAR-NK Cell Therapies<\/a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Manila Times<\/font><br \/><a href=\"https:\/\/news.google.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?oc=5\">source<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>DAAN Biotherapeutics and GC Cell Sign Exclusive Technology Transfer Agreement for Tumor Antigen-Specific Antibody Sequence to Advance CAR-T and CAR-NK Cell Therapies&nbsp;&nbsp;The Manila Timessource<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-40445","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.cyberneus.com\/index.php?rest_route=\/wp\/v2\/posts\/40445","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cyberneus.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cyberneus.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cyberneus.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cyberneus.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=40445"}],"version-history":[{"count":0,"href":"https:\/\/www.cyberneus.com\/index.php?rest_route=\/wp\/v2\/posts\/40445\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.cyberneus.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=40445"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cyberneus.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=40445"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cyberneus.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=40445"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}